the market?
CYCLACEL PHARMACEUTICALS, INC.
NASDAQ: CYCC
3.04
0.04
(1.33%)
| Today's Open | $3.05 |
|---|---|
| Previous Close | $3.00 |
| Daily Range | $2.99 - $3.07 |
| 52-Week Range | $2.73 - $8.18 |
| Market Cap | $33.1M |
| P/E Ratio | -1.18 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 828,653 |
| Average Daily Volume | 205,688 |
| Current FY EPS | $0.00 |
How do you think CYCC
will perform against the market?
Top CYCC Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
July 2, 2011
With the dilutive financing today, all the pieces are in place for Cyclacel to rebound in the second half: 1. Bad news out of the way. Selciclib failed in the APPRAISE trial and will no longer weigh … More
zzlangerhans (< 20)
Submitted
May 10, 2011
Cyclacel is carving out a new spike this month, undoubtedly related to ASCO's approach. But the company's presentations are unlikely to contain meaningful new data - the SEAMLESS phase III trial of sa … More
News & Commentary
Cyclacel Announces New Stock Issue
The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.5 of Last Week's Biggest Losers
These five stocks bucked last week's uptrend by taking a dive.5 of Last Week's Biggest Winners
These five stocks soared over the past few days.Why These 3 Biotech Stocks Are Winning
Gilead, Amarin, and Cyclacel are all up over 5%Sector
Healthcare
Industry
Drugs
CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description
A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/
